Big Gain For Matinas BioPharma Holdings, Inc.
Fri, Oct 06, 2023 at 07:37 PM
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) jumped higher at $0.19, representing a gain of 31%. On Fri, Oct 06, 2023, MTNB:NYSEMKT touched a New 2-Week High of $0.19. The stock appeared on our News Catalysts scanner on Thu, Sep 28, 2023 at 07:15 AM in the 'MISCELLANEOUS' category. From Fri, Sep 22, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Apr 20, 2023 at $0.75 with a volume of 2M+.
About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 292.16%
- ParaZero Technologies Ltd. (PRZO:NASDAQ), 79.12%
- T2 Biosystems, Inc. (TTOO:NASDAQ), 35.67%
- Vaccinex, Inc. (VCNX:NASDAQ), 34.11%
- American Oncology Network Inc. (AONC:NASDAQ), 32.06%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 30.99%
- Akso Health Group (AHG:NASDAQ), 29.57%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 27.38%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 27.27%
- Omega Therapeutics Inc. (OMGA:NASDAQ), 25.79%